Epaminurad clinical trials
How each study uses epaminurad is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
4 studies that test it; most in 2023 (1)
| Year | Studies |
|---|---|
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 4 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses epaminurad is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- To Evaluate the Safety and Pharmacokinetic Characteristics in Healthy VolunteersCompletedPhase 1JW PharmaceuticalNCT07374406Written as Epaminurad 9 mg (JW Pharmaceutical)
- A Therapeutic Confirmatory Study of Epaminurad Versus Febuxostat in Gout PatientsCompletedPhase 3JW PharmaceuticalNCT05815901Written as Epaminurad 6 mg
- PK,PD and DDI of Epaminurad and C2406 in Healthy VolunteersCompletedPhase 1JW PharmaceuticalNCT06665425Written as Epaminurad 9 mg
- PK,PD and DDI of Epaminurad and Naproxen in Healthy VolunteersCompletedPhase 1JW PharmaceuticalNCT06435442Written as Epaminurad, Naproxen
Codes
What other systems call epaminurad · ClinicalTrials.gg INT014246
- UNII (FDA) 0YP1ME85GHEPAMINURADOne source FDA
- NCI Thesaurus C166441EpaminuradOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 0YP1ME85GH | EPAMINURAD | One source FDA |
| NCI Thesaurus | C166441 | Epaminurad | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.